| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 6.35% | -6.75% | 46.99% | 49/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 4.32% | -3.57% | 88.65% | 40/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.29% | -13.26% | -74.47% | 46/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 8.97% | -14.08% | 31.72% | 35/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 6.81% | -16.65% | 52.01% | 52/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.48% | -27.86% | 69.7% | 43/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.64% | -49.13% | -74.71% | 46/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 10.44% | -57.35% | 27.78% | 30/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.17% | 2% | 31.56% | 38/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 6.21% | -53.24% | 19.65% | 25/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 5.19% | 2% | -78.8% | 8/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 24.48% | -12.98% | 84.34% | 2/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 13.28% | -2.99% | -52.79% | 5/159 | 2.16% | 福元医药 | 25.41% | 行业排名> |
| 2021-12-31 | 28.13% | 34.98% | 105.48% | 5/159 | 0.75% | 小方制药 | 34.81% | 行业排名> |
| 2021-06-30 | 13.69% | 2% | -34.31% | 5/159 | 2.94% | 退市金泰 | 10.74% | 行业排名> |
| 2020-12-31 | 20.84% | -19.91% | -19.91% | 20/159 | 3.58% | 人福医药 | 6.82% | 行业排名> |
| 2019-12-31 | 26.02% | -15.93% | -15.93% | 11/159 | 2.53% | 小方制药 | 71.99% | 行业排名> |
| 2018-12-31 | 30.95% | 2% | 2% | 3/159 | 6.99% | 汇宇制药 | 39.25% | 行业排名> |

微信公众号
证券之星APP



